Stellantis introduced early Monday that it plans a second U.S. battery plant to assist help American EV manufacturing. 

With a memorandum of understanding signed between Stellantis and Samsung SDI Monday, the businesses search to begin manufacturing on the facility in 2027 and “an preliminary annual manufacturing capability of 34 gigawatt-hours.” However the location stays undisclosed and “at the moment underneath assessment,” based on a launch.

The second battery plant will fall underneath the identical StarPlus Power three way partnership as its first U.S. facility at the moment being in-built Kokomo, Indiana and resulting from ramp up in early 2025.

Moreover, Stellantis reported that the Indiana plant will intention for an annual manufacturing of 33 gigawatt-hours, up from 23 when the mission was introduced. 

STLA Massive platform – Stellantis EVs

Stellantis’ different proposed battery plant, a three way partnership with LG Power Answer, had been stalled till earlier this month over points by which “the Canadian authorities has not delivered on what was agreed to.” 

As of July 5, the businesses reported the mission was again on, with the plant resulting from begin manufacturing in 2024, ramping as much as an annual output of greater than 45 gigawatt-hours. 

That 4.5-million-square-foot manufacturing facility was beforehand resulting from be accomplished by the top of 2023. The location can even be serving as a know-how middle for cell, module, and battery-pack improvement for EVs, hybrids, and plug-in hybrids, however the firm hasn’t but commented on how this delay may have an effect on these plans. 

Jeep Recon

Stellantis additionally hasn’t but supplied an replace on whether or not this impacts the timeline for the launch of upcoming EVs, probably together with the Ram 1500 REV electrical truck, a Dodge electrical muscle automobile, and a Jeep Recon that might act as a completely electrical “brother” to the Wrangler. 

Samsung SDI cells have precedent in Stellantis’ U.S. EV lineup. The unique Fiat 500e that first arrived for restricted U.S. sale a decade in the past was outfitted with cells from that firm.